metricas
covid
Vacunas Lo más citado
Información de la revista

Lo más citado

Datos disponibles en articúlos publicados a partir del año 2014

11
A review on non-small cell lung cancer
Sunil Kumar Verma, Minakshi Pandey, Renu Khare, Devendra Singh
Vacunas. 2024;25:239-53
11
9
Immunoinformatics strategy for designing a multi-epitope chimeric vaccine to combat Neisseria gonorrhoeae
P. Priyamvada, Rayapadi G. Swetha, Rupsha Dasgupta, Anand Anbarasu, Sudha Ramaiah
Vacunas. 2024;25:385-402
9
8
Recent advancements in cancer vaccines: A systematic review
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, Minakshi Pandey, Avinash Sharma, Himanshu Pandey, Anshu Mishra
Vacunas. 2024;25:97-108
8
5
Post COVID-19 era: Re-emergence of known and future (X) viral pathogens
Pryanka Thakur, Vikram Thakur, Monika Sapra, Sonakshi Srivastava, Sanjay Kumar Singh Patel
Vacunas. 2024;25:403-14
5
5
The emerging applications of niosome as a nanotechnology-based approach in vaccine delivery
Marjan Talebi, Negar Bozorgchami, Rouzbeh Almasi Ghale, Hadi Esmaeeli, Azamsadat Moosavizadeh, Ali Aghajani, Bahareh Farasati Far, Saeed Aminzadeh
Vacunas. 2024;25:374-84
5
4
COVID-19 vaccine rumour and resistance in Indonesia: Analysing vaccine hesitancy and cultural myths circulated on online platforms
Rachmah Ida, Sri Endah Kinasih, Syafrida Nurrachmi Febriyanti, Ratih Puspa, Muhammad Saud, Mohd Syuhaidi Abu Bakar
Vacunas. 2024;25:313-22
4
4
Effectiveness of the vaccine (Covaxin®) on different age groups of people: A pilot study
Vivek Chauhan, Adrija Rakshit, Vivek Kumar Dhiman, Gaytri Mahajan, Akash Pnadey, Shamsher Singh Kanwar, Devendra Singh
Vacunas. 2024;25:152-60
4